Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ibuprofen Lysine
2. 57469-76-8
3. Ibuprofen Dl-lysine
4. Ibuprofen D,l-lysinate
5. 079x7dl13m
6. (rs)-2-(4-(2-methylpropyl)phenyl)propanoic Acid D,l-lysine Salt
7. 2,6-diaminohexanoic Acid Compound With 2-(4-isobutylphenyl)propanoic Acid (1:1)
8. (rs)-2-[4-(2-methylpropyl)phenyl]propanoic Acid D,l-lysine Salt
9. (2s)-2,6-diaminohexanoic Acid;2-[4-(2-methylpropyl)phenyl]propanoic Acid
10. Neoprofen;ibuprofen-lys
11. Starbld0004237
12. Schembl44616
13. Unii-079x7dl13m
14. Dtxsid50432054
15. Bcp27681
16. Akos015963349
17. Ac-19865
18. Ac-32764
19. Ft-0670261
20. Ft-0670262
21. Lysine, Mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
22. Dl-lysine, Mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)
23. Lysine, Alpha-methyl-4-(2-methylpropyl)benzeneacetate (1:1)
24. Dl-lysine, Mono(.alpha.-methyl-4-(2-methylpropyl)benzeneacetate)
25. Lysine, .alpha.-methyl-4-(2-methylpropyl)benzeneacetate (1:1)
26. Lysine, Mono(.alpha.-methyl-4-(2-methylpropyl)benzeneacetate)
27. Benzeneacetic Acid, .alpha.-methyl-4-(2-methylpropyl)-, Compd. With Lysine (1:1)
28. Benzeneacetic Acid, Alpha-methyl-4-(2-methylpropyl)-, Compd. With Lysine (1:1)
Molecular Weight | 352.5 g/mol |
---|---|
Molecular Formula | C19H32N2O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 9 |
Exact Mass | 352.23620751 g/mol |
Monoisotopic Mass | 352.23620751 g/mol |
Topological Polar Surface Area | 127 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 309 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ANALYTICAL
ABOUT THIS PAGE
A Ibuprofen Lysine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibuprofen Lysine, including repackagers and relabelers. The FDA regulates Ibuprofen Lysine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibuprofen Lysine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ibuprofen Lysine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ibuprofen Lysine supplier is an individual or a company that provides Ibuprofen Lysine active pharmaceutical ingredient (API) or Ibuprofen Lysine finished formulations upon request. The Ibuprofen Lysine suppliers may include Ibuprofen Lysine API manufacturers, exporters, distributors and traders.
click here to find a list of Ibuprofen Lysine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ibuprofen Lysine DMF (Drug Master File) is a document detailing the whole manufacturing process of Ibuprofen Lysine active pharmaceutical ingredient (API) in detail. Different forms of Ibuprofen Lysine DMFs exist exist since differing nations have different regulations, such as Ibuprofen Lysine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ibuprofen Lysine DMF submitted to regulatory agencies in the US is known as a USDMF. Ibuprofen Lysine USDMF includes data on Ibuprofen Lysine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ibuprofen Lysine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ibuprofen Lysine suppliers with USDMF on PharmaCompass.
A Ibuprofen Lysine written confirmation (Ibuprofen Lysine WC) is an official document issued by a regulatory agency to a Ibuprofen Lysine manufacturer, verifying that the manufacturing facility of a Ibuprofen Lysine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ibuprofen Lysine APIs or Ibuprofen Lysine finished pharmaceutical products to another nation, regulatory agencies frequently require a Ibuprofen Lysine WC (written confirmation) as part of the regulatory process.
click here to find a list of Ibuprofen Lysine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ibuprofen Lysine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ibuprofen Lysine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ibuprofen Lysine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ibuprofen Lysine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ibuprofen Lysine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ibuprofen Lysine suppliers with NDC on PharmaCompass.
Ibuprofen Lysine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ibuprofen Lysine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ibuprofen Lysine GMP manufacturer or Ibuprofen Lysine GMP API supplier for your needs.
A Ibuprofen Lysine CoA (Certificate of Analysis) is a formal document that attests to Ibuprofen Lysine's compliance with Ibuprofen Lysine specifications and serves as a tool for batch-level quality control.
Ibuprofen Lysine CoA mostly includes findings from lab analyses of a specific batch. For each Ibuprofen Lysine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ibuprofen Lysine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ibuprofen Lysine EP), Ibuprofen Lysine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ibuprofen Lysine USP).
LOOKING FOR A SUPPLIER?